Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 286
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00514995 | Sodium Oxybate in the Treatment of Binge Eating Disorder | ||
| NCT05044819 | Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution | ||
| NCT04195945 | CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients | ||
| NCT04530604 | Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) | ||
| NCT00628498 | Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study | ||
| NCT02953548 | Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) | ||
| NCT04899050 | Epidiolex in Typical Absence Seizures | ||
| NCT05178316 | A Study of JZP150 in Adults With Posttraumatic Stress Disorder | ||
| NCT00097708 | Experimental Medication For the Treatment of Generalized Anxiety Disorder | ||
| NCT02718755 | Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies | ||
| NCT04541082 | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | ||
| NCT02038699 | A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer | ||
| NCT05875974 | A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy | ||
| NCT03406702 | CX-8998 for Absence Seizures | ||
| NCT04133480 | Investigation of Cognitive Outcomes With Cannabidiol Oral Solution | ||
| NCT03555955 | A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 | ||
| NCT02596997 | Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease | ||
| NCT01604265 | A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis | ||
| NCT00678795 | A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis | ||
| NCT02806895 | Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA | ||
| NCT06143839 | VYxeoS Liposomal Italian Observational Study iN the Real Practice | ||
| NCT01241344 | Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease | ||
| NCT01886105 | Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma | ||
| NCT01610700 | An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients | ||
| NCT02348593 | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" | ||
| NCT02271347 | An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease | ||
| NCT05122650 | A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) | ||
| NCT02420080 | A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304 | ||
| NCT04323254 | Language of Sleepiness | ||
| NCT01769170 | A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients | ||
| NCT00594256 | Sodium Oxybate in Schizophrenia With Insomnia | ||
| NCT04894591 | To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) | ||
| NCT00710424 | A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy | ||
| NCT02647190 | Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older | ||
| NCT04145531 | An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) | ||
| NCT00457951 | A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD | ||
| NCT03436953 | A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease | ||
| NCT02348606 | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" | ||
| NCT05918640 | Lurbinectedin in FET-Fused Tumors | ||
| NCT00681538 | A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) | ||
| NCT05629702 | ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids | ||
| NCT01217112 | GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes | ||
| NCT06012929 | A Study of ONC201 for Refractory Meningioma | ||
| NCT05772429 | Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting | ||
| NCT04610658 | Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC | ||
| NCT00788892 | Trial of CPX-351 in Newly Diagnosed Elderly AML Patients | ||
| NCT02369471 | A Study of GWP42006 in People With Focal Seizures - Part A | ||
| NCT01599234 | A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis | ||
| NCT02525692 | Oral ONC201 in Adult Recurrent Glioblastoma | ||
| NCT00003966 | Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation |
